Redweik G, Stromberg Z, Van Goor A, Mellata M
Poult Sci. 2020; 99(2):752-762.
PMID: 32029160
PMC: 7587825.
DOI: 10.1016/j.psj.2019.10.038.
Wardle E
World J Surg. 1982; 6(5):616-23.
PMID: 7135991
DOI: 10.1007/BF01657880.
Mattsby-Baltzer I, Hanson L, Olling S, Kaijser B
Infect Immun. 1982; 35(2):647-53.
PMID: 7035370
PMC: 351090.
DOI: 10.1128/iai.35.2.647-653.1982.
Michael J, Mallah I
Infect Immun. 1981; 33(3):784-7.
PMID: 6793518
PMC: 350779.
DOI: 10.1128/iai.33.3.784-787.1981.
Brade H, Galanos C
Infect Immun. 1983; 42(1):250-6.
PMID: 6194116
PMC: 264551.
DOI: 10.1128/iai.42.1.250-256.1983.
Serum antibodies against common antigens of bacterial lipopolysaccharides in healthy adults and in patients with multiple myeloma.
Stoll C, Schedel I, Peest D
Infection. 1985; 13(3):115-9.
PMID: 4030107
DOI: 10.1007/BF01642869.
The immunogenicity and antigenicity of lipid A are influenced by its physicochemical state and environment.
Brade L, Brandenburg K, KUHN H, Kusumoto S, Macher I, Rietschel E
Infect Immun. 1987; 55(11):2636-44.
PMID: 3666956
PMC: 259954.
DOI: 10.1128/iai.55.11.2636-2644.1987.
Isolation and characterization of murine monoclonal antibodies specific for gram-negative bacterial lipopolysaccharide: association of cross-genus reactivity with lipid A specificity.
Bogard Jr W, Dunn D, Abernethy K, Kilgarriff C, Kung P
Infect Immun. 1987; 55(4):899-908.
PMID: 3549565
PMC: 260436.
DOI: 10.1128/iai.55.4.899-908.1987.
Characterization of murine monoclonal antibodies to Escherichia coli J5.
Miner K, Manyak C, Williams E, Jackson J, Jewell M, Gammon M
Infect Immun. 1986; 52(1):56-62.
PMID: 3514463
PMC: 262197.
DOI: 10.1128/iai.52.1.56-62.1986.
Endotoxin neutralization with rabbit antisera to Escherichia coli J5 and other gram-negative bacteria.
Warren H, Novitsky T, Bucklin A, Kania S, Siber G
Infect Immun. 1987; 55(7):1668-73.
PMID: 3298063
PMC: 260576.
DOI: 10.1128/iai.55.7.1668-1673.1987.
Immunotherapeutic advances in the treatment of gram-negative bacterial sepsis.
Dunn D
World J Surg. 1987; 11(2):233-40.
PMID: 3296482
DOI: 10.1007/BF01656407.
Monoclonal antibodies to salmonella lipopolysaccharide: functional analysis of anti-lipid A antibodies.
Ward D, Michalek S, McGhee J
Clin Exp Immunol. 1988; 72(1):157-63.
PMID: 3293850
PMC: 1541515.
Production of potent polyclonal antibodies to bacterial membrane amphiphiles.
Ibrahim G, Lyons M
Med Microbiol Immunol. 1987; 176(6):305-13.
PMID: 3123902
DOI: 10.1007/BF00194890.
Inhibition of lipopolysaccharide mitogenicity with characterized anti-lipid A monoclonal antibodies.
Girard R, Chaby R
Immunology. 1985; 56(3):481-7.
PMID: 2867028
PMC: 1453740.
Characterization of two different antibody specificities recognizing distinct antigenic determinants in free lipid A of Escherichia coli.
Brade L, Brade H
Infect Immun. 1985; 48(3):776-81.
PMID: 2581900
PMC: 261260.
DOI: 10.1128/iai.48.3.776-781.1985.
Binding activity of a murine anti-lipid A monoclonal antibody.
Elkins K, Metcalf E
Infect Immun. 1985; 48(2):597-600.
PMID: 2580797
PMC: 261394.
DOI: 10.1128/iai.48.2.597-600.1985.
Effect of lipopolysaccharide and lipid A on mouse liver pyruvate kinase activity.
Smith S, Snyder I
Infect Immun. 1975; 12(5):993-8.
PMID: 1104489
PMC: 415387.
DOI: 10.1128/iai.12.5.993-998.1975.
Effect of active and passive immunizations with lipid A and salmonella minnesota Re 595 on gram-negative infections in mice.
Hodgin L, Drews J
Infection. 1976; 4(2):5-10.
PMID: 789248
DOI: 10.1007/BF01638340.
Immunization with R mutants of Salmonella minnesota. II. Comparison of the protective effect of immunization with lipid A and the Re mutant.
Bruins S, Stumacher R, Johns M, McCabe W
Infect Immun. 1977; 17(1):16-20.
PMID: 407161
PMC: 421075.
DOI: 10.1128/iai.17.1.16-20.1977.
Lipid A and anti-lipid A.
Mattsby-Baltzer I, Kaijser B
Infect Immun. 1979; 23(3):758-63.
PMID: 378836
PMC: 414231.
DOI: 10.1128/iai.23.3.758-763.1979.